HRP20080422T3 - Satraplatin za liječenje rezistentnih ili refraktornih tumora - Google Patents

Satraplatin za liječenje rezistentnih ili refraktornih tumora

Info

Publication number
HRP20080422T3
HRP20080422T3 HR20080422T HRP20080422T HRP20080422T3 HR P20080422 T3 HRP20080422 T3 HR P20080422T3 HR 20080422 T HR20080422 T HR 20080422T HR P20080422 T HRP20080422 T HR P20080422T HR P20080422 T3 HRP20080422 T3 HR P20080422T3
Authority
HR
Croatia
Prior art keywords
treatment
resistant
refractor
satraplatin
tumors
Prior art date
Application number
HR20080422T
Other languages
English (en)
Croatian (hr)
Inventor
Caligiuri Maureen
Wosikowski-Buters Katja
Maria Casazza Anna
Original Assignee
Gpc Biotech Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gpc Biotech Ag filed Critical Gpc Biotech Ag
Publication of HRP20080422T3 publication Critical patent/HRP20080422T3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HR20080422T 2004-02-18 2005-02-18 Satraplatin za liječenje rezistentnih ili refraktornih tumora HRP20080422T3 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54609704P 2004-02-18 2004-02-18
PCT/EP2005/001733 WO2005077385A2 (en) 2004-02-18 2005-02-18 Methods for treating resistant or refractory tumors

Publications (1)

Publication Number Publication Date
HRP20080422T3 true HRP20080422T3 (hr) 2008-09-30

Family

ID=34860531

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20080422T HRP20080422T3 (hr) 2004-02-18 2005-02-18 Satraplatin za liječenje rezistentnih ili refraktornih tumora

Country Status (19)

Country Link
US (1) US20080058411A1 (https=)
EP (2) EP1967189A1 (https=)
JP (1) JP2007523123A (https=)
CN (1) CN1933829A (https=)
AT (1) ATE397924T1 (https=)
AU (1) AU2005211937B2 (https=)
CA (1) CA2555811A1 (https=)
CY (1) CY1108780T1 (https=)
DE (1) DE602005007471D1 (https=)
DK (1) DK1720540T3 (https=)
ES (1) ES2308451T3 (https=)
HR (1) HRP20080422T3 (https=)
IL (1) IL177555A0 (https=)
PL (1) PL1720540T3 (https=)
PT (1) PT1720540E (https=)
RS (1) RS50605B (https=)
SI (1) SI1720540T1 (https=)
WO (1) WO2005077385A2 (https=)
ZA (1) ZA200607780B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2004964A3 (cs) * 2004-09-14 2006-03-15 Pliva-Lachema A. S. Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
EP1905437A1 (en) * 2006-09-24 2008-04-02 GPC Biotech AG Treatment of pain using satraplatin
EP1905439A1 (en) * 2006-09-24 2008-04-02 GPC Biotech AG Second line treatment of metastatic hormone refractory prostate cancer using satraplatin
FR2906533B1 (fr) 2006-09-28 2013-02-22 Pf Medicament Procede de generation d'anticorps actifs contre un antigene de resistance,anticorps obtenus par ledit procede et leurs utilisations
JP2010518088A (ja) * 2007-02-09 2010-05-27 ポニアード ファーマシューティカルズ， インコーポレイテッド カプセル化されたピコプラチン
RU2455991C1 (ru) * 2011-07-05 2012-07-20 Учреждение Российской академии медицинских наук Научно-исследовательский институт фармакологии Сибирского отделения РАМН Средство, препятствующее развитию нарушений в легочной ткани при цитостатическом воздействии

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4329299A (en) 1979-08-23 1982-05-11 Johnson, Matthey & Co., Limited Composition of matter containing platinum
GB8328218D0 (en) 1983-10-21 1983-11-23 Johnson Matthey Plc Oral compositions
GB8416048D0 (en) 1984-06-22 1984-07-25 Johnson Matthey Plc Anti-tumour compounds of platinum
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4710384A (en) 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules
US5072011A (en) 1988-02-02 1991-12-10 Johnson Matthey, Inc. Pt(IV) complexes
US5244919A (en) 1988-02-02 1993-09-14 Johnson Matthey, Inc. Pt(IV) complexes as anti-tumor agents
US4942184A (en) 1988-03-07 1990-07-17 The United States Of America As Represented By The Department Of Health And Human Services Water soluble, antineoplastic derivatives of taxol
GB8806044D0 (en) 1988-03-14 1988-04-13 Johnson Matthey Plc Platinum coordination compounds
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (it) 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5440056A (en) 1992-04-17 1995-08-08 Abbott Laboratories 9-deoxotaxane compounds
US6025473A (en) * 1992-10-27 2000-02-15 Queen's University At Kingston Multidrug resistance proteins
AP9300587A0 (en) 1992-11-12 1995-05-05 Glaxo Inc Water soluble camptothecin derivatives.
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
US5475322A (en) 1993-10-12 1995-12-12 Wang Laboratories, Inc. Clock frequency multiplying and squaring circuit and method
US6210917B1 (en) 1993-12-29 2001-04-03 The Regents Of The University Of California Method for suppressing multiple drug resistance in cancer cells
GB9408218D0 (en) 1994-04-26 1994-06-15 Johnson Matthey Plc Improvements in platinum complexes
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US5547982A (en) 1995-02-27 1996-08-20 Johnson Matthey, Inc. Anti-tumor platinum complexes
US20040072889A1 (en) * 1997-04-21 2004-04-15 Pharmacia Corporation Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
US6413953B1 (en) 1999-04-13 2002-07-02 Anormed Inc. Pt(IV) antitumor agent
DK1165576T3 (da) 1999-04-13 2006-03-27 Anormed Inc Fremgangsmåde til fremstilling af amin-platin-komplekser
US7179588B1 (en) 1999-05-20 2007-02-20 Board Of Regents Of The University Of Texas System Assay for the detection of paclitaxel resistant cells in human tumors
US6380405B1 (en) 1999-09-13 2002-04-30 Nobex Corporation Taxane prodrugs
CA2307393A1 (en) * 2000-05-01 2001-11-01 The University Of British Columbia Ginsenoside chemotherapy
US6894049B1 (en) 2000-10-04 2005-05-17 Anormed, Inc. Platinum complexes as antitumor agents
US7351542B2 (en) 2002-05-20 2008-04-01 The Regents Of The University Of California Methods of modulating tubulin deacetylase activity
US6933302B2 (en) 2002-06-03 2005-08-23 California Pacific Medical Center Nitrogen-based homo-camptothecin derivatives
GB0312407D0 (en) * 2003-05-29 2003-07-02 Pharma Mar Sau Treatment

Also Published As

Publication number Publication date
EP1720540A2 (en) 2006-11-15
JP2007523123A (ja) 2007-08-16
CN1933829A (zh) 2007-03-21
WO2005077385A2 (en) 2005-08-25
HK1094313A1 (en) 2007-03-30
AU2005211937B2 (en) 2009-02-26
US20080058411A1 (en) 2008-03-06
PL1720540T3 (pl) 2008-11-28
EP1720540B1 (en) 2008-06-11
ES2308451T3 (es) 2008-12-01
CA2555811A1 (en) 2005-08-25
DE602005007471D1 (de) 2008-07-24
WO2005077385A3 (en) 2005-11-10
EP1967189A1 (en) 2008-09-10
RS50605B (sr) 2010-05-07
ZA200607780B (en) 2008-04-30
DK1720540T3 (da) 2008-10-06
SI1720540T1 (sl) 2008-12-31
PT1720540E (pt) 2008-09-10
CY1108780T1 (el) 2014-04-09
ATE397924T1 (de) 2008-07-15
IL177555A0 (en) 2006-12-10
AU2005211937A1 (en) 2005-08-25

Similar Documents

Publication Publication Date Title
NO20073790L (no) Kjemiske forbindelser
NO20073788L (no) Kjemiske forbindelser
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
TW200716606A (en) Chemical compounds
TW200800963A (en) Chemical compounds
BRPI0510177B8 (pt) composto, composição farmacêutica e uso do mesmo
NO2017019I1 (no) Diarylhydantoinforbindelse, farmasøytisk sammensetning og anvendelse derav
EP2400847A4 (en) SPECIFIC DIARYLHYDANTOIN AND DIARYLTHIOHYDANTOINE COMPOUNDS
PT1951730E (pt) Derivados de pirimidina ligados a heteroalquilo
CY1111433T1 (el) Φαρμακευτικο τυποποιημενο παρασκευασμα δεσιταβινης
CL2004000917A1 (es) Compuestos derivados de tiazol; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de enfermedades mediadas por 3-cinasa de dosfatidilnositol tal como enfermedades respiratorias, alergias, artritis reumatoide, osteoa
ECSP078062A (es) Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen
MX2009001014A (es) Mediacion de citotoxicidad de celulas que evidencian expresion de cd63 en superficie.
PL1809288T3 (pl) Zastosowanie pochodnych 1,4-bis-(3-aminoalkilo)piperazyny do leczenia chorób neurodegeneracyjnych
TW200616977A (en) Enantiomers of selected fused heterocyclics and uses thereof
HRP20080422T3 (hr) Satraplatin za liječenje rezistentnih ili refraktornih tumora
SE0400708D0 (sv) New compounds and use thereof
EA200702672A1 (ru) Производные индола, обладающие противоопухолевой активностью
TW200621260A (en) Selected fused heterocyclics and uses thereof
TW200745133A (en) New compounds II
TNSN07300A1 (en) 1,3-thiazole-5-carboxamides useful as cancer chemotherapeutic agents
ATE432933T1 (de) Flavopereirinderivate zur krebstherapie
EA200601842A1 (ru) D-гомо-17-хлор-16(17)-ен-стероиды
UA93197C2 (ru) Производные пиразолиламинопиридина, способ их получения, их применения и фармацевтическая композиция (варианты)